RYTHM, Inc. (RYM)
Stock analysis · NASDAQ · Consumer Defensive · Tobacco
RYTHM, Inc. (RYM) is a publicly traded company in the Consumer Defensive sector. Latest price: $16.49. Market cap $35.44M. Trailing PE -1.47. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About RYTHM, Inc.
RYTHM, Inc. is a company that delivers solutions for the cannabis and industrial hemp sectors throughout the United States. Among its offerings are hemp-derived tetrahydrocannabinol (THC) beverages, which it markets to consumers under the Señorita brand. Founded in 2016, the firm's main office is situated in Troy, Michigan. It was previously known as Agrify Corporation until it adopted its current name, RYTHM, Inc., in August 2025.
Valuation
| P/E (TTM) | -1.47× |
|---|---|
| P/S (TTM) | 0.69× |
| P/B | 0.91× |
| P/FCF (TTM) | 27.30× |
| EV / EBITDA | -6.56× |
| EV / Sales | 1.45× |
| Earnings Yield | -8.90% |
| Free Cash Flow Yield | 3.66% |
Fundamentals
| Enterprise Value | $74.15M |
|---|---|
| Revenue (TTM) | $51.01M |
| Net Income (TTM) | -$3.16M |
| Free Cash Flow (TTM) | $7.05M |
| Net Debt | $38.71M |
| Working Capital | -$39.08M |
| Gross Margin | 68.43% |
| Operating Margin | -30.32% |
| Net Margin | -6.20% |
| Return on Equity | -12.61% |
| Return on Invested Capital | -1.35% |
Peers
Recent News
- Contrasting RYTHM (NASDAQ:RYM) & Dare Bioscience (NASDAQ:DARE)
- Analyzing RYTHM (NASDAQ:RYM) and Assembly Biosciences (NASDAQ:ASMB)
- Takeda Pharmaceutical (NYSE:TAK) vs. RYTHM (NASDAQ:RYM) Financial Survey
- Contrasting RYTHM (NASDAQ:RYM) and Fortress Biotech (NASDAQ:FBIO)
- RYTHM Introduces Lifted Lemon, a New THC Twist on Iced Tea and Lemonade
Related
Browse more tickers: sitemap